Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in adult cohort: a real-life Italian tertiary centre experience

J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e380-e383. doi: 10.1111/jdv.16219. Epub 2020 May 22.

Authors

S Ribero^#¹, M T Giura^#¹, R Viola², A Ramondetta¹, N Siliquini¹, P Cardone¹, L Tonella¹, P Quaglino¹, P Dapavo¹, M Panzone¹, M Ortoncelli¹, M T Fierro¹

Affiliations

¹ Medical Sciences Department, Dermatologic Clinic, University of Turin, Turin, Italy.
² Faculty of Medicine, University of Turin, Turin, Italy.

^# Contributed equally.

PMID: 31960496
DOI: 10.1111/jdv.16219

No abstract available

Publication types

Letter

MeSH terms

Adult
Antibodies, Monoclonal, Humanized
Dermatitis, Atopic* / drug therapy
Eczema*
Humans
Italy
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
dupilumab